Pharmaceuticals

Pharmacovigilance Market Overview 2026–2030 With Insights On Industry Developments

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Pharmacovigilance Market During The Forecast Period?

The pharmacovigilance market has experienced substantial growth in recent years. It is forecast to grow from $9.64 billion in 2025 to $10.86 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. The expansion witnessed in previous periods is largely attributable to factors such as increasing adverse drug reaction reporting, the broader reach of global pharmaceutical approvals, rising clinical trial volumes, the establishment of international drug safety regulations, and the growing usage of drugs for chronic diseases.

The pharmacovigilance market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $17.41 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected growth during the forecast period is largely driven by factors such as the increased use of real-world data, a rise in approvals for biologics and biosimilars, the growing intricacy of combination therapies, the broadening scope of pharmacovigilance in developing regions, and a heightened emphasis on patient safety results. Key trends expected during this period involve the expansion of post-marketing surveillance efforts, the increasing embrace of real-world evidence for safety monitoring, stricter regulatory oversight and compliance demands, the growing practice of outsourcing pharmacovigilance services, and the consolidation of safety data from multiple sources into integrated platforms.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Which Major Drivers Are Influencing The Expansion Of The Pharmacovigilance Market?

The escalating research and development activities are poised to propel the pharmacovigilance market. By allocating resources to R&D, pharmaceutical companies can devise novel and advanced medications featuring enhanced safety profiles. Thorough preclinical and clinical assessments during the drug development phase enable the prompt identification of potential safety issues, allowing for the implementation of appropriate risk mitigation strategies. Moreover, R&D initiatives contribute to the enhancement of technologies for adverse event monitoring, data analysis, and signal detection, thereby facilitating the early discovery of adverse drug reactions in the post-marketing period. For instance, in 2023, according to the Office for National Statistics, a UK-based, government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 billion in 2023, up from £16.1 billion in 2022, marking an 8.2% rise. Consequently, the increasing research and development endeavors have supported the growth of the pharmacovigilance market.

How Is Segmentation Applied In The Pharmacovigilance Market Segment Analysis?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Which Trends Are Influencing Demand In The Pharmacovigilance Market?

Leading companies in the pharmacovigilance market are increasingly concentrating on artificial intelligence (AI) to boost their operational efficiency. AI has the capability to enhance the effectiveness and precision of pharmacovigilance activities, ultimately leading to improved patient outcomes. By leveraging AI, pharmaceutical firms can optimize their workflows, refine data management, and accelerate drug discovery, while simultaneously cutting costs and elevating safety standards. For instance, in August 2024, the Government of India rolled out the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software aids in the collection and examination of adverse events associated with medicines and medical devices, simplifying the reporting process for both consumers and healthcare professionals. This initiative substantially reinforces India’s pharmacovigilance infrastructure by ensuring a more extensive capture of safety data and strengthening drug safety monitoring. The ADRMS aims to improve the efficiency of drug safety oversight and compliance with standards, thereby helping to position India as a key player in the global pharmaceutical industry.

Who Are The Companies Participating In The Pharmacovigilance Market Environment?

Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.

Get The Full Pharmacovigilance Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Which Region Has The Greatest Market Share In The Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmacovigilance Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Browse Through More Reports Similar to the Global Pharmacovigilance Market 2026, By The Business Research Company

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Medical Devices Vigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-devices-vigilance-global-market-report

Cosmetovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/cosmetovigilance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795